Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics

Contributed by: PR Newswire

Tags

Alimentiv-GI-Sci-Advi

More Like This

PR Newswire associated0

Alimentiv and Satisfai Health Extend Partnership to Accelerate Development of Innovative Imaging Technologies to Tackle GI Disease Challenges

PR Newswire associated0

Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

PR Newswire associated0

Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials

Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego

PR Newswire associated0

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

Inotrem Receives Milestone Funding From the Crohn’s & Colitis Foundation IBD Ventures Program to Advance Its Inflammatory Bowel Disease Pipeline

PR Newswire associated0

CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at 'ECCO 2025'; Clinical Entry Targeted for 2026

Data Presented at UEG Week 2023 Further Support the Potential of Celltrion’s Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease